These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 33181785)

  • 1. Dried Blood Spot as an Alternative to Plasma/Serum for SARS-CoV-2 IgG Detection, an Opportunity to Be Sized to Facilitate COVID-19 Surveillance Among Schoolchildren.
    Amendola A; Bianchi S; Gori M; Barcellini L; Colzani D; Canuti M; Giacomet V; Fabiano V; Folgori L; Zuccotti GV; Tanzi E
    Pediatr Infect Dis J; 2021 Jan; 40(1):e46-e47. PubMed ID: 33181785
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of Dried Blood Spots and Venous Blood for the Detection of SARS-CoV-2 Antibodies in a Population of Nursing Home Residents.
    Meyers E; Heytens S; Formukong A; Vercruysse H; De Sutter A; Geens T; Hofkens K; Janssens H; Nys E; Padalko E; Deschepper E; Cools P
    Microbiol Spectr; 2021 Oct; 9(2):e0017821. PubMed ID: 34549995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples.
    Swank Z; Michielin G; Yip HM; Cohen P; Andrey DO; Vuilleumier N; Kaiser L; Eckerle I; Meyer B; Maerkl SJ
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33945500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure.
    Demonbreun AR; McDade TW; Pesce L; Vaught LA; Reiser NL; Bogdanovic E; Velez MP; Hsieh RR; Simons LM; Saber R; Ryan DT; Ison MG; Hultquist JF; Wilkins JT; D'Aquila RT; Mustanski B; McNally EM
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33755598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Dried Blood Spots to Quantitatively Detect Anti-SARS-CoV-2 IgG Antibodies by ELISA: A Validation Study.
    Ylade M; Aziz AB; Daag JV; Crisostomo MV; Agrupis KA; Maronilla MA; Sye Lim Hong C; Kim HY; Njau I; Lopez MHJ; Deen J; Kim DR; You YA; Kang SSY; Marks F; Tadesse BT
    Am J Trop Med Hyg; 2024 Aug; 111(2):391-395. PubMed ID: 38917817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of SARS-CoV-2 IgG antibodies in dried blood spots.
    Turgeon CT; Sanders KA; Granger D; Nett SL; Hilgart H; Matern D; Theel ES
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115425. PubMed ID: 34116343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
    Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
    Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-throughput Anti-SARS-CoV-2 IgG testing platform for COVID-19.
    Du J; Chu E; Zhang D; Lu CM; Zhang A; Sha MY
    J Virol Methods; 2021 Jan; 287():114009. PubMed ID: 33152411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
    Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
    J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of SARS-CoV-2 Antibodies in a Multistate Academic Medical Center.
    Carter RE; Theel ES; Breeher LE; Swift MD; Van Brunt NA; Smith WR; Blanchfield LL; Daugherty EA; Chapital AB; Matson KM; Bews KA; Johnson PW; Domnick RA; Joyce DE; Geyer HL; Granger D; Hilgart HR; Turgeon CT; Sanders KA; Matern D; Nassar A; Sampathkumar P; Hainy CM; Orford RR; Vachon CM; Didehban R; Morice WG; Ting HH; Williams AW; Gray RJ; Thielen KR; Farrugia G;
    Mayo Clin Proc; 2021 May; 96(5):1165-1174. PubMed ID: 33958053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive Detection of SARS-CoV-2-Specific Antibodies in Dried Blood Spot Samples.
    Morley GL; Taylor S; Jossi S; Perez-Toledo M; Faustini SE; Marcial-Juarez E; Shields AM; Goodall M; Allen JD; Watanabe Y; Newby ML; Crispin M; Drayson MT; Cunningham AF; Richter AG; O'Shea MK
    Emerg Infect Dis; 2020 Dec; 26(12):2970-2973. PubMed ID: 32969788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient Identification of High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Plasma Samples by Pooling Method.
    Nguyen KD; Wirz OF; Röltgen K; Pandey S; Tolentino L; Boyd SD; Pham TD
    Arch Pathol Lab Med; 2021 Oct; 145(10):1221-1227. PubMed ID: 34101801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay.
    Brinc D; Biondi MJ; Li D; Sun H; Capraru C; Smookler D; Zahoor MA; Casey J; Kulasingam V; Feld JJ
    Viruses; 2021 May; 13(6):. PubMed ID: 34067361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dried blood spots as alternative sampling material for serological detection of anti-SARS-CoV-2 antibodies using established ELISAs.
    Weisser H; Steinhagen K; Höcker R; Borchardt-Lohölter V; Anvari Ö; Kern PM
    Clin Chem Lab Med; 2021 Apr; 59(5):979-985. PubMed ID: 33554537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of various serological assays for novel SARS-COV-2.
    Sacristan MS; Collazos-Blanco A; Cintas MIZ; García AS; de Villavicencio CY; Maestre MM
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):963-968. PubMed ID: 33236270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-fast, high throughput and inexpensive detection of SARS-CoV-2 seroconversion using Ni
    Conzentino MS; Santos TPC; Selim KA; Wagner B; Alford JT; Deobald N; Paula NM; Rego FGM; Zanette DL; Aoki MN; Nardin JM; Huergo MCC; Reis RA; Huergo LF
    Anal Biochem; 2021 Oct; 631():114360. PubMed ID: 34481802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay.
    Mulchandani R; Brown B; Brooks T; Semper A; Machin N; Linley E; Borrow R; Wyllie D;
    J Clin Virol; 2021 Mar; 136():104739. PubMed ID: 33588354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.